全文获取类型
收费全文 | 9926篇 |
免费 | 803篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 140篇 |
儿科学 | 350篇 |
妇产科学 | 249篇 |
基础医学 | 1318篇 |
口腔科学 | 127篇 |
临床医学 | 1307篇 |
内科学 | 1722篇 |
皮肤病学 | 120篇 |
神经病学 | 925篇 |
特种医学 | 375篇 |
外科学 | 1230篇 |
综合类 | 120篇 |
一般理论 | 8篇 |
预防医学 | 1091篇 |
眼科学 | 204篇 |
药学 | 680篇 |
中国医学 | 7篇 |
肿瘤学 | 776篇 |
出版年
2023年 | 58篇 |
2022年 | 82篇 |
2021年 | 215篇 |
2020年 | 152篇 |
2019年 | 228篇 |
2018年 | 255篇 |
2017年 | 187篇 |
2016年 | 199篇 |
2015年 | 241篇 |
2014年 | 275篇 |
2013年 | 492篇 |
2012年 | 602篇 |
2011年 | 571篇 |
2010年 | 344篇 |
2009年 | 291篇 |
2008年 | 473篇 |
2007年 | 465篇 |
2006年 | 458篇 |
2005年 | 382篇 |
2004年 | 419篇 |
2003年 | 383篇 |
2002年 | 340篇 |
2001年 | 237篇 |
2000年 | 241篇 |
1999年 | 236篇 |
1998年 | 98篇 |
1997年 | 74篇 |
1996年 | 78篇 |
1995年 | 69篇 |
1994年 | 66篇 |
1993年 | 61篇 |
1992年 | 166篇 |
1991年 | 148篇 |
1990年 | 154篇 |
1989年 | 142篇 |
1988年 | 120篇 |
1987年 | 127篇 |
1986年 | 139篇 |
1985年 | 124篇 |
1984年 | 97篇 |
1983年 | 75篇 |
1982年 | 60篇 |
1981年 | 56篇 |
1979年 | 105篇 |
1978年 | 80篇 |
1977年 | 67篇 |
1976年 | 60篇 |
1974年 | 51篇 |
1973年 | 59篇 |
1972年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
151.
John L. Tonkinson Philip Marder Sherri L. Andis Richard M. Schultz Lynn S. Gossett Chuan Shih L. G. Mendelsohn 《Cancer chemotherapy and pharmacology》1997,39(6):521-531
Purpose: Cell cycle-related events in CCRF-CEM lymphocytic leukemia cells were examined subsequent to inhibition of thymidylate synthase
(TS) or GAR formyltransferase (GARFT) and prior to cell death or stasis. Methods: Cell populations were treated with the GARFT inhibitors 6R-5,10-dideazatetrahydrofolate (lometrexol) or LY309887, the TS inhibitor ZD1694, or the multitargeted antifolate LY231514.
DNA content, nucleoside precursor incorporation and proliferating cell nuclear antigen (PCNA) expression as functions of drug
treatment were assessed by multiparameter flow cytometry. Cellular respiration was measured by MTT analysis and apoptosis
was detected by extraction of DNA fragments. Results: Cell populations treated for up to 96 h with lometrexol or LY309887 did not replicate and maintained a cell cycle distribution
with distinct G1, S and G2/M regions. The number of S phase cells in treated populations was slightly elevated relative to control as measured by DNA
content and PCNA. However, these cells were unable to incorporate 5-bromodeoxyuridine (BrdU). Throughout treatment, cells
incubated with GARFT inhibitors maintained intact membranes and respired at a level comparable to untreated cells. In contrast,
ZD1694 as well as LY231514, induced synchronization of the treatment population at the G1/S interface within 12 h of drug addition. This was followed by synchronous entry of the population into S phase. After 24 h
of treatment, more than 90% of the cells were capable of incorporating BrdU and stained positive for PCNA. DNA fragmentation
occurred in cells treated with ZD1694 or LY231514 but not in those treated with GARFT inhibitors. In addition, the viable
cells remaining after 24–48 h of treatment with ZD1694 or LY231514 were respiring at twice the level of untreated cells. Conclusion: These results demonstrate that the distinct endpoints of GARFT and TS inhibition are preceded by distinct cell cycle and
metabolic alterations.
Received: 1 April 1996 / Accepted: 5 September 1996 相似文献
152.
153.
I Talon F Becmeur I Kauffmann R Moog A Schultz S Grandadam 《Archives de pédiatrie》2006,13(4):361-363
We report on the case of a 9-year-old girl who presented vaginal bleeding which led to the diagnosis of vaginal hemangioma. Such localisation is rare, and requires a clinical follow-up by vaginoscopy. A spontaneous regression can be expected but, at this time, the progress of puberty and future fertility are unknown. 相似文献
154.
M J Sutcliffe J J Shuster H N Sather B M Camitta J Pullen K R Schultz M J Borowitz P S Gaynon A J Carroll N A Heerema 《Leukemia》2005,19(5):734-740
Chromosome aberrations have a major role in pediatric acute lymphoblastic leukemia (ALL) risk assignment. The Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG) independently assessed the significance of trisomy for chromosomes 4, 10, and 17 in National Cancer Institute (NCI) Standard- and High-Risk ALL. Data from 1582 (CCG) and 3902 (POG) patients were analyzed. Eight-year event-free survivals (EFS) of 91% (CCG) and 89% (POG) (P < 0.001) were achieved in patients assigned to NCI Standard Risk whose leukemic cells had simultaneous trisomies 4, 10, and 17. Both groups showed the degree of favorable prognostic importance increased with the actual number of favorable trisomies. POG analyses also demonstrated hyperdiploidy (> or =53 chromosomes) was less of an independently significant prognostic factor in the absence of these key trisomies. This finding supported conclusions from previous CCG and POG studies that specific trisomies are more important than chromosome number in predicting outcome in pediatric B-precursor ALL. In NCI Higher Risk patients, the number of favorable trisomies was not prognostically significant, but showed the same trend. Moreover, specific trisomies 4, 10, and 17 remain associated with favorable prognosis in Standard-Risk B-precursor ALL, even in the context of very different treatment approaches between the groups. 相似文献
155.
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. 总被引:4,自引:0,他引:4
Michael Atkins Meredith Regan David McDermott James Mier Eric Stanbridge Amanda Youmans Philip Febbo Melissa Upton Mirna Lechpammer Sabina Signoretti 《Clinical cancer research》2005,11(10):3714-3721
PURPOSE: Renal cancer response to interleukin 2 (IL-2) therapy and patient survival has been correlated with tumor histology and carbonic anhydrase IX (CAIX) expression. In an effort to confirm and expand these observations, we examined CAIX expression in pathology specimens from renal cancer patients who had previously received IL-2 therapy. EXPERIMENTAL DESIGN: Paraffin-embedded tissue sections of renal cancer were immunostained with the MN-75 monoclonal antibody to CAIX and expression levels were correlated with histologic findings and clinical outcome. RESULTS: Tissue specimens were obtained from 66 patients; 27 of whom (41%) had responded to IL-2-based therapy. Fifty-eight specimens were assessed as clear cell, with 56, 33, and 4 having alveolar, granular, and papillary features, respectively. Twenty-four (36%), 31 (47%), and 11 (17%) were classified into good, intermediate, and poor prognosis groups according to the Upton pathology model. Forty-one specimens (62%) had high CAIX expression. Twenty-one of 27 (78%) responding patients had high CAIX expressing tumors compared with 20 of 39 (51%) nonresponders (odds ratio, 3.3; P = 0.04). Median survival was prolonged (P = 0.04) and survival >5 years was only seen in high CAIX expressers. In patients with intermediate pathologic prognosis, all nine responders had high CAIX expression versus 11 of 22 nonresponders. A resultant group with good pathologic prognosis alone or with intermediate pathologic prognosis and high CAIX contained 26 of 27 (96%) responders compared with 18 of 39 (46%) nonresponders (odds ratio, 30; P < 0.01) and exhibited longer median survival (P < 0.01). CONCLUSIONS: CAIX expression seems to be an important predictor of outcome in renal cell carcinoma patients receiving IL-2-based therapy and may enhance prognostic information obtained from pathology specimens. 相似文献
156.
Donald J Buchsbaum M B Khazaeli Donald B Axworthy Jody Schultz Tandra R Chaudhuri Kurt R Zinn Mark Carpenter Albert F LoBuglio 《Clinical cancer research》2005,11(22):8180-8185
PURPOSE: This study examined a pretarget radioimmunotherapy strategy for treatment of an i.p. tumor model (LS174T). EXPERIMENTAL DESIGN: The strategy used regional administration (i.p.) of a novel targeting molecule composed of four CC49 anti-tumor-associated glycoprotein 72 (TAG-72) single-chain antibodies linked to streptavidin as a fusion protein (CC49 fusion protein); 24 hours later, a synthetic clearing agent was administered i.v. to produce hepatic clearance of unbound CC49 fusion protein/synthetic clearing agent complexes. Four hours later, a low molecular weight radiolabeled reagent composed of biotin conjugated to the chelating agent 7,10-tetra-azacyclododecane-N,N',N',N'-tetraacetic acid (DOTA) complexed with (111)In-, (90)Y-, or (177)Lu-DOTA-biotin was injected. RESULTS: Radiolocalization to tumor sites was superior with i.p. administration of radiolabeled DOTA-biotin as compared with i.v. administration. Imaging and biodistribution studies showed excellent tumor localization of radioactivity with (111)In- or (177)Lu-DOTA-biotin. Tumor localization of (111)In-DOTA-biotin was 43% ID/g and 44% ID/g at 4 and 24 hours with the highest normal tissue localization in the kidney with 6% ID/g at 48 and 72 hours. Therapy studies with (90)Y-DOTA-biotin at doses of 400 to 600 microCi or (177)Lu-DOTA-biotin at doses of 600 to 800 microCi produced significant prolongation of survival compared with controls (P = 0.03 and P < 0.01). CONCLUSIONS: Pretarget radioimmunotherapy using regional administration of CC49 fusion protein and i.p. (90)Y- or (177)Lu-DOTA-biotin represents a successful therapeutic strategy in the LS174T i.p. tumor model and this strategy may be applicable to human trials in patients with i.p. ovarian cancer. 相似文献
157.
158.
159.
160.
David A. Six Yanqiu Yuan Jennifer A. Leeds Timothy C. Meredith 《Antimicrobial agents and chemotherapy》2014,58(1):153-161
The β-acetoacetyl-acyl carrier protein synthase FabY is a key enzyme in the initiation of fatty acid biosynthesis in Pseudomonas aeruginosa. Deletion of fabY results in an increased susceptibility of P. aeruginosa
in vitro to a number of antibiotics, including vancomycin and cephalosporins. Because antibiotic susceptibility can be influenced by changes in membrane lipid composition, we determined the total fatty acid profile of the ΔfabY mutant, which suggested alterations in the lipid A region of the lipopolysaccharide. The majority of lipid A species in the ΔfabY mutant lacked a single secondary lauroyl group, resulting in hypoacylated lipid A. Adding exogenous fatty acids to the growth media restored the wild-type antibiotic susceptibility profile and the wild-type lipid A fatty acid profile. We suggest that incorporation of hypoacylated lipid A species into the outer membrane contributes to the shift in the antibiotic susceptibility profile of the ΔfabY mutant. 相似文献